Laurence Turka

Laurence Turka

Corporate Officer/Principal bei
Immune Tolerance Network
68 Jahre
Commercial Services
Health Technology
Consumer Services

Profil

Laurence Turka is the founder of Rheos Medicines, Inc. which was founded in 2018.
He is currently the Deputy Director at Immune Tolerance Network.
He is also a Member of the Association of American Physicians since 2003 and a Member of the American Society for Clinical Investigation since 1995.
Dr. Turka has held several former positions including Chairman-Scientific Counselors at the National Institute of Allergy & Infectious Diseases, President at The American Society of Transplantation, Professor at Harvard Medical School, and Editor in Chief at The Journal of Clinical Investigation.
Dr. Turka received his doctorate degree from Yale School of Medicine.
Additionally, Dr. Turka was the Chief Scientific Officer & Head-Research at Rubius Therapeutics, Inc. from 2021 to 2023.

Aktive Positionen von Laurence Turka

UnternehmenPositionBeginn
Corporate Officer/Principal -
Corporate Officer/Principal 01.01.1995
Corporate Officer/Principal 01.01.2003

Ehemalige bekannte Positionen von Laurence Turka

UnternehmenPositionEnde
RUBIUS THERAPEUTICS Technik-/Wissenschafts-/F&E-Leiter 31.01.2023
Gründer 01.01.2020
Corporate Officer/Principal -
Corporate Officer/Principal -
Präsident -
Sehen Sie sich die Erfahrung von Laurence Turka im Detail an

Ausbildung von Laurence Turka

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

49

Beziehungen ersten Grades

10

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen10

Commercial Services

Health Technology

Government

Commercial Services

Consumer Services

Commercial Services

Commercial Services

Consumer Services

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Laurence Turka
LETZTE CHANCE | -40 %: Die besten Tools exklusiv für Abonnenten - Ihr Schlüssel zu den Top-Investitionen der Zukunft!
T
:
:
PROFITIEREN SIE JETZT